NOVO NORDISK'S DENECIMIG (MIM8) DEMONSTRATED POSITIVE RESULTS IN LONG TERM SAFETY AND EFFICACY IN PHASE 3 HEMOPHILIA A FRONTIER EXTENSION STUDY AT ISTH 2026

Reuters · 1d ago

Please log in to view news